Larvol Delta - Cognition-Therapeutics-Completes-Type-C-Meeting-with-FDA-for-Zervimesine-CT1812-in-Dementia-with-Lewy-Bodies

Elayta (zervimesine) - Cognition Therap

https://www.globenewswire.com/news-release/2026/01/27/3226367/0/en/Cognition-Therapeutics-Completes-Type-C-Meeting-with-FDA-for-Zervimesine-CT1812-in-Dementia-with-Lewy-Bodies.html

Jan 27, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next